Importantly, by immunostaining and electrophysiological analyses, synaptic kainate receptors (KARs) have been shown to be impaired in a mouse model of AD, in addition to AMPA and NMDA receptor dysregulation [121]. This evidence concerns the gene KARS1 and Alzheimer disease.